This inventor holds 5 USPTO granted patents. Top assignee: Northern Illinois University. Active years: 2015-2018.
Location History:
- New York, NY (US) (2015 - 2017)
- Dekalb, IL (US) (2018)
Company Filing History:
Years Active: 2015-2018
Title: James P. Dillon: Innovator in Ophthalmic and Therapeutic Technologies
Introduction
James P. Dillon is a prominent inventor based in New York, NY, recognized for his groundbreaking contributions to the field of ophthalmic treatments and therapeutic innovations. With a total of five patents to his name, Dillon has made significant strides in developing systems that enhance the delivery of medicinal substances.
Latest Patents
Dillon's recent patents highlight his commitment to addressing complex medical challenges. One of his notable inventions involves a "Timed release of substances to treat ocular disorders." This system provides a non-invasive method for sustained delivery of ophthalmic substances directly to the eye to combat various diseases and conditions. Utilizing liposomes and inverted micelles as vehicles, this invention improves the delivery methods, which include coating lenses or injecting substances into the eye.
His second key patent, titled "Therapeutic uses of glutathione mimics," outlines a prodrug with antioxidant properties. This invention presents a method for treating oxidative stress by administering a phosphorylated compound with a thiol group. The innovative approach involves managing the bioavailability of thiol compounds to effectively treat conditions related to oxidative stress and mitigate radiation damage to healthy tissues.
Career Highlights
Dillon's work at Northern Illinois University has allowed him to cultivate both academic and practical expertise in his field. His innovative mindset has led to numerous advancements in therapeutic techniques, specifically targeting eye health and oxidative stress treatment.
Collaborations
Throughout his career, Dillon has engaged in collaborative efforts with notable colleagues, including Elizabeth R. Gaillard and Jason Friedrichs. These partnerships have played a crucial role in the development and refinement of his inventions, enhancing their practical applications and effectiveness.
Conclusion
James P. Dillon stands out as a visionary inventor whose work has the potential to transform the landscape of ophthalmic and therapeutic treatments. His achievements not only reflect his dedication to innovation but also the importance of collaboration in advancing medical science. As he continues to push the boundaries of technology, the impact of his patents will likely be felt for years to come.
